Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Emerg Infect Dis ; 25(7): 1373-1376, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-31211673

RESUMEN

We describe a sexual network consisting of 1 nonbinary-gendered participant and 2 male and 4 female participants in Australia, 2018. Six of 7 participants had oropharyngeal gonorrhea in the absence of urogenital gonorrhea. This observation supports a new paradigm of gonorrhea transmission in which oropharyngeal gonorrhea can be transmitted through tongue kissing.


Asunto(s)
Gonorrea/epidemiología , Gonorrea/microbiología , Faringitis/epidemiología , Faringitis/microbiología , Trabajadores Sexuales , Adulto , Australia/epidemiología , Femenino , Genoma Bacteriano , Genómica/métodos , Gonorrea/historia , Gonorrea/transmisión , Historia del Siglo XXI , Humanos , Masculino , Neisseria gonorrhoeae/clasificación , Neisseria gonorrhoeae/genética , Neisseria gonorrhoeae/aislamiento & purificación , Faringitis/historia , Vigilancia en Salud Pública
7.
Indian J Med Res ; 115: 215-41, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12440194

RESUMEN

Research on Group A streptococci (GAS) before 1950 paved the way for successful clinical trials to prevent acute rheumatic fever (ARF) by treating the prior streptococcal infection with penicillin. Prevention of ARF has led to almost complete disappearance of rheumatic heart disease in the industrialized world, but has yet to be accomplished in developing countries, where most of the world's populations reside. Twenty years of research beginning in 1918 by Lancefield and others delineated the modern classification of haemolytic streptococci and led to the recognition that only Group A is responsible for the pharyngitis that causes ARF. M-protein, identified as a major virulence factor, is a powerful inhibitor of phagocytosis, and antibodies to it promote type-specific phagocytosis and therefore type-specific immunity. Other virulent properties of GAS include a bulky capsule, as well as extracellular toxins such as streptolysins S and O and streptococcal proteinase. McCarty and others pursued the cell biology of GAS and identified the cellular localization of various antigenic components. The discovery of purified M-protein as a helical coiled-coiled fibrillar protein has sparked development of M-protein vaccine. US, UK, and Trinidad scientists described differences between streptococcal infections of the throat and skin and noted particularly that many of the GAS M-types that cause impetigo are less likely to cause pharyngitis. GAS impetigo may cause acute glomerulonephritis, but such infections do not result in ARF. The changing manifestations of disease over time and the evolution of microbes are common themes in medicine today. These themes are relevant to GAS pharyngitis and ARF, especially the decline in the incidence of severe ARF and the decrease in severity of GAS pharyngitis. Research on GAS bacteriophages led to the discovery of a relationship between lysogenic GAS and production of erythrogenic toxin and has broadened approaches to the molecular epidemiology of GAS virulence. The 21st century begins with determination of the complete genome sequence of M-1, M-18, and M-3 strains of GAS. These studies provide evidence for phage-encoded toxins, high-virulence phenotypes, and clone emergence. This research will reveal genetic processes at the molecular level that control the emergence and decline of streptococcal diseases in different places and times and the shifting patterns in clinical manifestations.


Asunto(s)
Penicilinas/historia , Infecciones Estreptocócicas/historia , Streptococcus pyogenes , Animales , Historia del Siglo XX , Humanos , Penicilinas/uso terapéutico , Faringitis/tratamiento farmacológico , Faringitis/historia , Faringitis/inmunología , Polisacáridos Bacterianos/química , Polisacáridos Bacterianos/inmunología , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/inmunología , Infecciones Estreptocócicas/microbiología , Streptococcus pyogenes/genética , Streptococcus pyogenes/inmunología , Streptococcus pyogenes/fisiología
8.
Clin Infect Dis ; 33(6): 806-14, 2001 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-11512086

RESUMEN

In the first half of the twentieth century, the group A streptococcus (GAS) was established as the sole etiologic agent of acute rheumatic fever (ARF). In the century's latter half, the clinical importance of variation in the virulence of strains of GAS has become clearer. Although still obscure, the pathogenesis of ARF requires primary infection of the throat by highly virulent GAS strains. These contain very large hyaluronate capsules and M protein molecules. The latter contain epitopes that are cross-reactive with host tissues and also contain superantigenic toxic moieties. In settings where ARF has become rare, GAS pharyngitis continues to be common, although it is caused by GAS strains of relatively lower virulence. These strains, however, colonize the throat avidly and stubbornly. Molecularly distinct pyoderma strains may cause acute glomerulonephritis, but they are not rheumatogenic, even though they may secondarily colonize and infect the throat. Guidelines for the diagnosis, treatment, and prevention of GAS pharyngitis and ARF are reviewed with particular reference to the prevalence of the latter in the community.


Asunto(s)
Fiebre Reumática , Artritis Reactiva/etiología , Vacunas Bacterianas/farmacología , Corea/etiología , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Miocarditis/diagnóstico , Miocarditis/etiología , Faringitis/etiología , Faringitis/historia , Faringitis/microbiología , Faringitis/prevención & control , Fiebre Reumática/etiología , Fiebre Reumática/historia , Fiebre Reumática/microbiología , Fiebre Reumática/prevención & control , Infecciones Estreptocócicas/etiología , Infecciones Estreptocócicas/historia , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/prevención & control , Streptococcus pyogenes/genética , Streptococcus pyogenes/patogenicidad , Streptococcus pyogenes/fisiología , Estados Unidos/epidemiología , Virulencia
15.
Pediatrics ; 40(2): 187, 1967 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-5006582
16.
Minn Med ; 49(7): 1185-90, 1966 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-5328381
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...